Beijing on June 2, according to foreign media reports, Microsoft Monday said it will acquire the pharmaceutical giant Merck's Rosetta biological software company (hereinafter referred to as "Rosetta"), part of the assets to further expand the medical technology business. Rosetta development of medical research in the field of data management software.
Microsoft said the deal is completed, its Amalga life sciences software platform (hereinafter referred to as "Amalga") will add many new features, including genes, genome, metabolism group and other complex data management. Neither side disclosed the price of the deal.
Under the agreement, Merck will use in research activities in Amalga. Amalga can help researchers to manage research activities in the data.
The deal is expected to be completed by the end of June 2009. Microsoft will integrate Rosetta technology in early 2010 released a new version of Amalga.